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INTRODUCTION
Depressive disorder, one of the most common psychiatric dis-
orders, tends to result in functional impairment. Mortality rates 
related to suicide are higher in patients with depression than in 
those with other mental diseases, and depression tends to recur. 
For these reasons, depression is considered to occupy an impor-
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tant position among mental disorders.
1  
A recent epidemiological study in South Korea in 2006 found 
that the prevalence of major depressive disorder was 3.6% high-
er than the estimate from 2 years earlier.
2    
According to a cross-national epidemiological study of ma-
jor depression, the lifetime prevalence of this disorder varies 
from 1.5% in Taiwan and 2.9% in Korea to 19.0% in Beirut.
3 
Ustun et al. also showed various prevalence rates in 15 countries, 
finding the highest rate in South America, the middle rate in the 
US and Europe, and the lowest rate in East Asia.
4 Lower esti-
mated prevalence rates in Asian than in Western countries re-
flect the influences of ethnicity, culture, and different research 
methodologies.
5 The social stigma attached to depression con-
tributes to the underestimation of the prevalence of depression 
in Korea. Indeed, the cultural context affects the way individu-
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als express the disorder. Asian people tend to express depression 
as somatic symptoms, whereas Europeans and North Americans 
are prone to emphasizing more affective symptoms.
6 Japanese 
women are likely to express emotional complaints by referring 
to physical problems or worries about childcare rather than by 
expressing depressed feelings.
7 Chinese women frequently 
mention a “wind inside the head” and a “wind illness” as physical 
symptoms of depression.
8
Using data based on the Korean version of the Center for Ep-
idemiologic Studies Depression scales (CES-D), Kim et al.
9 found 
a factor structure that differed from those reported in studies in 
Western countries.
10 Namely, among Korean patients, somatic 
symptoms and affective symptoms were combined into one fac-
tor, and emotional hardship and interpersonal issues constituted 
another factor. The unique factor structure of depressive symp-
toms in Korean individuals suggests the need for different ap-
proaches to the diagnosis and treatment of depression in Korea. 
According to a study investigating the current use of depres-
sion rating scales in a Korean mental health setting, psychiatrists 
and clinical psychologists use the Beck Depressive Inventory 
(BDI)
11 most frequently.
12
The BDI, which is characterized by good reliability and va-
lidity, is widely favored in many countries. However, its items 
have limited ability to accurately screen for the symptoms of de-
pression as expressed by Korean people. For instance, if ques-
tions addressing physical dimensions of depression are limited 
to topics such as sleep disturbances, changes in appetite and weight, 
and somatic concerns, they cannot detect somatic symptoms 
such as chest pain, hot flashes, and dizziness that are often re-
ported by Korean patients with depressive disorder. The use of 
standardized Western tools may be culturally insensitive and in-
crease the risk of overlooking symptoms or signs that are preva-
lent in non-Western cultures.
13,14 Therefore, it is necessary to de-
velop a Korean tool for screening for depressive symptoms. 
Many domestic studies have attempted to standardize depres-
sion rating scales developed in Western cultures such as the BDI, 
the CES-D, the Zung Self-Rating Depression Scale (SDS),
15 
and the Geriatric Depression Scale (GDS).
16 However, no attempts 
to develop a domestic scale for depression have been reported 
thus far. 
This study was designed to develop a culturally sensitive 
self-report scale, the Lee and Rhee Depression Scale (LRDS), to 
measure depressive symptoms and screen for depressive dis-
order in Korea.
METHODS
Development of preliminary items
To develop the questions to be included in the LRDS, we trans-
lated existing depression scales into Korean and then performed 
structured interviews with patients suffering from depression to 
investigate their symptoms. The detailed procedure is described 
below.
Collection, analysis, and translation 
of existing depression scales
We collected depression scales developed in other countries. 
These included the BDI, CES-D, SDS, GDS, Hamilton Rating Sc-
ale for Depression (HAM-D),
17 Carroll Depression Scale (CDS),
18 
Montgomery-Asberg Depression Rating Scale (MADRS),
19 
Depression Self-Rating Scale (DSRS),
20 Depression scale in the 
MMPI-2,
21 Depressive Experiences Questionnaire (DEQ),
22  and 
Beck Hopelessness Scale (BHS).
23
We analyzed the content, reliability, validity, and other charac-
teristics of each scale. Several scales were translated into Korean. 
Translation was done jointly by two psychiatrists and a clinical 
psychologist, and questions deemed unsuitable for the Korean cul-
ture were modified through group discussions to fit the national 
context. Translated questions were collected to form the item pool. 
Collection of information about symptoms 
of depression among Koreans
The symptoms identified by Korean patients with depres-
sion were very important elements in composing the questions 
that constitute the LRDS. Thus, we examined inpatients and out-
patients in the Neuropsychiatric Department who were being treat-
ed for depression, focusing on their symptoms and on life 
events prior to the onset of depression. The patients’ symptoms 
and life events were examined through content analysis, and 
the results were used to create a candidate item pool. Holsti of-
fers a broad definition of content analysis as “any technique for 
making inferences by objectively and systematically identifying 
specified characteristics of messages.”
24
A survey of 302 patients with depression (85 males and 217 
females) at the psychiatric clinic of Anam Hospital of Korea 
University Medical Center concerning their main symptoms and 
life events identified 81 primary types of symptoms and 975 to-
tal symptoms. The rank order of frequency (n, % of total) of in-
dividual symptoms was as follows: insomnia (112, 11.5%), anxi-
ety (89, 9.1%), headache (85, 8.7%), indigestion (49, 5.0%), poor 
appetite (45, 4.6%), palpitations and rapid pulse (41, 4.2%), chest 
pain (37, 3.8%), heavy chest (35, 3.7%), agitation (36, 3.7%), nau-
sea and vomiting (35, 3.6%), loss of volition (34, 3.5%), depressed 
mood (33, 3.7%), stomach ache and abdominal discomfort (32, 
3.3%), and inertia (31, 3.2%). Additionally, some patients reported 
symptoms such as widespread pain, feelings of brachial and cru-
ral palsy, vertigo, weakness, and fatigue.
Preliminary item selection
As a result of discussions within the research team of senior 38  Psychiatry Investig 2012;9:36-44
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psychiatrists and clinical psychologists, we selected 127 prelimi-
nary items from 357 candidate items to address the ways in 
which Koreans experience depression.  
Final item selection
Of the 127 preliminary questions, items with low construct va-
lidity and reliability were eliminated through factor and reliabil-
ity analyses. The final scale contained 30 questions, including 
five questions for each of the six dimensions: negative thinking 
about the self, negative thinking about the future, worry and agi-
tation, depressed mood, somatization, and loss of volition. We 
used a 5-point self-report Likert scale ranging from 0 (“not at 
all”) to 4 (“absolutely yes”), yielding a total score from 0 to 120 
points; higher scores indicate more severe depression. The pro-
cedure for selecting items is depicted in the following diagram:
Sampling of subjects
Normative data
The current study aimed to develop a scale to measure de-
pression in non-clinical populations and to screen for depres-
sion in clinical settings. To this end, nationwide data were col-
lected from the non-clinical population of Korean adults through 
multistage mixed sampling that relied on area sampling, pro-
portional stratified sampling, and quota sampling. By combin-
ing these sampling methods, we enhanced the representative-
ness of the sample and minimized sampling error. A total of 4,000 
normal adults aged over 18 were recruited from throughout the 
country. The questionnaire included items pertaining to history 
of treatment for psychiatric disorders, age at onset, and duration 
of illness to exclude those with mental disorders.
Patient data
A total of 448 outpatients visiting the psychiatric clinic of Anam 
Hospital of Korea University participated in this study. Trained 
psychiatrists examined all subjects using the Structured Clini-
cal Interview for DSM-IV Axis I disorders (SCID-I).
25 The patient 
Step 1
Collection items from existing scales 
and from patients with depression
Total 357 items
Step 2
Preliminary items selection through 
discussion within the research team
Total 127 items
Step 3
Elimination of items 
with low validity and reliability 
through statistical analysis
Final 30 items
group included those with major depressive disorder without 
psychotic symptoms and dysthymic disorder. We obtained writ-
ten informed consent from all patients and control subjects, and 
the review committee of Korea University Medical Center ap-
proved this study.
Reliability and validity
Reliability was measured in terms of internal consistency us-
ing Cronbach’s alpha coefficient. Exploratory factor analysis was 
performed to evaluate construct validity. Confirmatory factor 
analysis was performed to identify the six dimensions constitut-
ing the full scale.         
Concurrent validity was assessed using Pearson correlation 
coefficients for scores on scales known to detect depressive 
symptoms: the BDI, the 21-item HAM-D, and the MMPI-2. 
The BDI is a widely used self-report scale designed to mea-
sure the severity of depressive symptoms and the extent of clin-
ical change over the treatment period. The HAM-D, considered 
by many to be the “gold standard,” is a clinician-rated scale for 
depression. The 21-item version of the HAM-D used in the pres-
ent study was modified from the original 17-item version by the 
addition of four items (diurnal variation, paranoid ideation, ob-
sessive/compulsive symptoms, and depersonalization/dereal-
ization). The MMPI-2, an upgraded and restandardized version 
of the MMPI, consists of 567 true/false self-report items. It con-
tains numerous scales to assess personality constructs within 
the normal range as well as psychopathological symptomatol-
ogy. As one of the most commonly used instrument, it has been 
translated into numerous languages around the world. The Ko-
rean version of MMPI-2
26 was used in this study.
Discriminant validity was evaluated by comparing the LRDS 
scores in the depressed and control groups via analysis of vari-
ance (ANOVA). Finally, receiver-operating-characteristic (ROC) 
analysis was performed to test the diagnostic utility of the scale for 
the identification of depression. ROC analysis, a method often 
used for evaluating the accuracy of diagnostic tests, provides a 
graph of the true-positive (sensitivity) versus the false-positive 
(1-specificity) rates.
27
Data were analyzed using SPSS 15.0 for Windows and AMOS 
7.0.
RESULTS
A final sample of 3,697 control subjects and 448 patients with 
depression were enrolled in the current study after excluding 
data with random responses or unanswered questions.  
Construct validity and reliability
Exploratory factor analysis was performed to identify factors 
reflected by each dimension of the scale. First, we calculated the SH Hwang et al. 
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Table 1. Factor loading and reliability for dimensions of the LRDS
Item
Factor Reliability
Loading H
2 Corrected alpha 
if item item-total
Correlation 
deleted
Negative thinking about the future
A18  I don’t think I have any hope 0.62 0.62 0.57 0.83
A108  My future is dark 0.82 0.82 0.72 0.79
A109  My future will be full of unhappiness rather than happiness 0.81 0.81 0.72 0.79
A110  I will fail to get what I truly want 0.76 0.76 0.68 0.79
A111  My future will be happier than my life is now 0.60 0.60 0.55 0.83
Eigenvalues   2.63             Cronbach’s α=0.84
Kaiser-Meyer-Olkin measure of sampling adequacy=0.85
Negative thinking about the self
A6  I think my life is a failure 0.66 0.43 0.56 0.76
A21  I feel worthless and shameful 0.70 0.49 0.60 0.73
A24  I still feel that life is worth living 0.50 0.25 0.44 0.78
A58  My life is futile and meaningless 0.74 0.55 0.63 0.72
A112  Nothing is going well for me 0.65 0.47 0.56 0.74
Eigenvalues  2.12                Cronbach’s α=0.78
Kaiser-Meyer-Olkin measure of sampling adequacy=0.82
Worry and agitation
A22  I feel distressed at my pitiful life 0.59 0.35 0.53 0.80
A33  I am anxious and restless 0.77 0.59 0.67 0.76
A34  I am sensitive and agitated 0.79 0.62 0.68 0.75
A35  I worry constantly without any reason 0.68 0.46 0.61 0.78
A36  I am afraid and almost in a panic 0.59 0.35 0.53 0.80
Eigenvalues  2.83                Cronbach’s α=0.81
Kaiser-Meyer-Olkin measure of sampling adequacy=0.83
Depressed mood
A2  I cannot overcome my depressed mood 
    even if my family or friends help me 
0.60 0.36 0.54 0.79
A13  I feel sad 0.65 0.42 0.57 0.78
A17  I am miserable and I feel like crying 0.77 0.59 0.66 0.75
A51  I spend most of my life in a depressed mood 0.66 0.43 0.58 0.78
A62  I sometimes cry because I am so depressed, 
    and I feel like that now
0.72 0.52 0.63 0.76
Eigenvalues 2.32               Cronbach’s α=0.81
Kaiser-Meyer-Olkin measure of sampling adequacy=0.84
Somatization
A113  My head aches and is heavy 0.72 0.52 0.64 0.79
A115  I feel pressure in my chest 0.73 0.53 0.64 0.79
A117  I have cold sweats and chills 0.69 0.48 0.61 0.80
A124  I have a fever in my whole body 0.72 0.52 0.64 0.79
A126  My mouth is dry and I have a bitter taste 0.66 0.43 0.59 0.81
Eigenvalues  2.47               Cronbach’s α=0.83
Kaiser-Meyer-Olkin measure of sampling adequacy=0.8340  Psychiatry Investig 2012;9:36-44
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measure of sampling adequacy (MSA) for each dimension. MSA 
is an index that compares the sum of the squares of the corre-
lation coefficients with the sum of the squares of the partial cor-
relation coefficients. Kaiser
28 described a MSA of 0.50 or less as 
unacceptable, rendering factor analysis is impossible; 0.50-
0.59 was described as miserable, 0.60-0.69 as mediocre, 0.70-
0.79 as middling, 0.80-0.89 as meritorious, and 0.90 or higher 
as marvelous. Reliability was measured by a coefficient of inter-
nal consistency (Cronbach’s α). Table 1 shows the results of fac-
tor analysis, reliability analysis, and the MSA for each dimension. 
Negative thinking about the future
The MSA for this dimension was 0.85; because this value met 
Kaiser’s criterion for meritorious, the data constituted an ade-
quate correlation matrix for factor analysis. One factor was ex-
tracted for this dimension; with an eigenvalue of 2.63, it explained 
52.60% of the total variance. The reliability of this dimension 
was good (Cronbach’s α=0.84).
Negative thinking about the self 
The MSA for this dimension was 0.82, which met Kaiser’s 
criterion for identification as meritorious. One factor was ex-
tracted for this dimension; its eigenvalue was 2.12, and it ex-
plained 42.40% of the total variance. The reliability of this di-
mension was satisfactory (Cronbach’s α=0.78).
Worry and agitation
The MSA for this dimension was 0.83, which met Kaiser’s 
criterion for meritorious. One factor was extracted for this di-
mension; its eigenvalue was 2.83, and it explained 56.60% of the 
total variance. The reliability of this dimension was good (Cron-
bach’s α=0.81).
Depressed mood
The MSA for this dimension was 0.84, which qualifies as mer-
itorious according to Kaiser. One factor was extracted for this di-
mension; its eigenvalue was 2.32, and it explained 46.40% of the 
total variance. The reliability of this dimension was good (Cron-
bach’s α=0.81).
Somatization
The MSA for this dimension was 0.83, which met Kaiser’s cri-
terion for meritorious. One factor was extracted for this dimen-
sion; its eigenvalue was 2.47, and it explained 49.40% of the total 
variance. The reliability of this dimension was good (Cronbach’s 
α=0.83).
Loss of volition 
The MSA of this dimension was 0.77, a middling level for fac-
tor analysis. One factor was extracted for this dimension; its ei-
genvalue was 1.88, and it explained 37.60% of the total variance. 
The reliability of this dimension was adequate (Cronbach’s α= 
0.74).
Verification of the six-factor model
We performed confirmatory factor analysis to verify that the 
LRDS was composed of six dimensions, as theoretically pro-
posed. This hypothesis was tested by maximum-likelihood esti-
mation using covariate matrix data. The results showed that the 
overall fit was good, with the following values for the represen-
tative agreement indices: χ
2=3381.59, RMSEA=0.06, RMR= 
0.04, standardized RMR=0.05, NFI=0.92, NNFI=0.91, CFI= 
0.92, and GFI=0.92. These agreement indices supported the six-
factor model.
Discriminant validity 
The means and standard deviations of scores on the LRDS 
are presented in Table 2. The means±standard deviations of those 
in the depressed group (n=448) were 63.99±22.87, and those for 
individuals in the control group (n=3,697) were 42.30±16.97. 
Table 1. Continued
Item
Factor Reliability
Loading H
2 Corrected alpha 
if item item-total
Correlation 
deleted
Loss of volition
A3  It is hard to concentrate on what I am doing 0.68 0.46 0.56 0.68
A4  Everything I do feels difficult 0.68 0.46 0.56 0.68
A9  I talk less than usual 0.46 0.21 0.40 0.74
A59  Recently I have lost any desire to solve my problems 0.62 0.39 0.52 0.70
A75  I feel helpless most of the time 0.61 0.37 0.51 0.70
Eigenvalues 1.88                Cronbach’s α=0.74
Kaiser-Meyer-Olkin measure of sampling adequacy=0.77
LRDS: Lee and Rhee Depression ScaleSH Hwang et al. 
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The ANOVA showed that the scores of women were significant-
ly higher than were those of men on the total scale and on the 
dimensions of worry and agitation, depressed mood, somatiza-
tion, and loss of volition (F=11.8, p<0.001). Hence, the compari-
son between patient and control groups was performed using 
an ANOVA with sex as a covariate. The results of the multivari-
ate analysis of covariance (MANCOVA) are presented in Table 
3. Scores on each factor were significantly higher in patients with 
depression than in the control group. 
Concurrent validity 
It is recommended that validation of a new scale includes evi-
dence of the relationship between the new scale and other mea-
sures that have already been extensively validated. In this study, 
all 448 subjects with depression completed the BDI and HAM-
D. Of these 448 subjects, 97 also completed the MMPI-2. Table 
4 presents the result of the correlation analysis using the afore-
mentioned data.
The Pearson correlation coefficients between the scores on 
the LRDS and those on the BDI and HAM-D were 0.78 (p< 
0.001) and 0.59 (p<0.001), respectively. These significant cor-
relations suggest that the LRDS has good convergent validity 
as a depression-screening instrument. 
The MMPI-2 has 10 clinical scales: Hypochondriasis, De-
pression, Hysteria, Psychopathic Deviate, Masculinity-Femi-
ninity, Paranoia, Psychasthenia, Schizophrenia, Hypomania, 
and Social Introversion. Each scale assesses different personali-
ty constructs and psychopathological symptoms. The Depres-
sion (D) scale was designed to measure various symptoms asso-
ciated with depression. The results of the statistical analysis in this 
study showed that LRDS scores were most strongly correlated 
with scores on the D scale (Pearson correlation coefficient=0.5, 
Table 2. The means and standard deviations of scores for each dimension and total score according to group and sex
Sex Dimension
Patient (N=448) Normal (N=3,697) Total (N=4,145)
Mean (SD) Mean (SD) Mean (SD)
Male Negative thinking about the future 09.59 (4.57) 06.16 (3.25) 06.37 (3.45)
Negative thinking about the self 09.11 (4.61) 06.22 (3.08) 06.40 (3.27)
Worry and agitation 10.71 (4.63) 06.47 (3.34) 06.73 (3.59)
Depressed mood 10.33 (4.93) 06.97 (3.45) 07.18 (3.65)
Somatization 09.57 (4.67) 06.81 (3.47) 06.98 (3.62)
Loss of volition 11.44 (4.66) 07.83 (3.18) 08.05 (3.40)
Total scale 60.75 (23.08) 40.48 (16.32) 41.72 (17.50)
Female Negative thinking about the future 09.40 (4.37) 06.14 (3.26) 06.62 (3.63)
Negative thinking about the self 09.46 (4.55) 06.43 (3.21) 06.88 (3.60)
Worry and agitation 11.40 (4.51) 07.03 (3.59) 07.67 (4.05)
Depressed mood 11.77 (4.81) 07.58 (3.61) 08.64 (4.07)
Somatization 11.14 (4.46) 07.76 (3.83) 08.26 (4.11)
Loss of volition 11.92 (4.56) 08.43 (3.41) 08.94 (3.81)
Total scale 65.07 (22.74) 43.91 (17.37) 47.01 (19.71)
Total Negative thinking about the future 09.45 (4.39) 06.34 (3.15) 06.51 (3.55)
Negative thinking about the self 09.37 (4.56) 06.34 (3.15) 06.67 (3.47)
Worry and agitation 11.23 (4.55) 06.77 (3.49) 07.26 (3.88)
Depressed mood 11.41 (4.88) 07.58 (3.61) 08.00 (4.00)
Somatization 10.75 (4.56) 07.32 (3.70) 07.69 (3.95)
Loss of volition 11.80 (4.58) 08.15 (3.32) 08.53 (3.63)
Total scale 63.99 (22.87) 42.30 (16.97) 44.67 (18.95)
SD: standard deviation
Table 3. MANOVA with sex as a covariate comparing scores of group
Dimensions  Group F p
Negative thinking about the future P>N 369.4 <0.001
Negative thinking about the self P>N 314.1 <0.001
Worry and agitation P>N 563.5 <0.001
Depressed mood P>N 361.1 <0.001
Somatization P>N 284.3 <0.001
Loss of volition P>N 404.8 <0.001
P: patient group, N: normal group. MANOVA: multivariate analy-
sis of variance42  Psychiatry Investig 2012;9:36-44
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p<0.001), and no correlation between scores on the LRDS 
and those on the Hypomania (Ma) scale, which measures hy-
pomanic symptoms (Pearson correlation coefficient=0.19, p> 
0.05), was observed. 
Diagnostic utility of the scale
ROC analysis was performed to test the diagnostic utility of 
this scale and to identify the appropriate cut-off score. Table 5 
presents the results of the ROC analysis, and Figure 1 shows the 
data related to diagnostic efficiency (area under the curve: AUC) 
for the overall scale and its dimensions. The diagnostic utility of 
the full scale was significant at 77.7% (p<0.001); the diagnostic 
utility of each dimension was also significant.
Preparation of national norms
Because scores on the overall scale and its dimensions differed 
significantly according to age and sex, we constructed norm ta-
bles by age and sex. For each norm score, we used the T-score 
at which the mean was 50 and the standard deviation was 10. 
Norm tables for men and women and for age groups are pre-
sented in the Appendix.
DISCUSSION
All currently used tools for screening for depression in Korea 
originated in Western countries. Despite the good validity and 
reliability of those scales, they are limited in their ability to de-
tect depressive symptoms in Korean patients given the many eth-
nic and cultural differences that affect mental disorders. Hence, 
the limitations of currently used Western tools may increase the 
risk of missing symptoms or signs in non-Western populations. 
This study attempted to develop a culturally sensitive measure 
to rate depression and to assess the validity and reliability of this 
measure. 
This LRDS addressed six dimensions and posed five ques-
tions for each dimension, yielding a total of 30 questions. The 
results of the exploratory factor analysis showed that each di-
mension represented a single factor, and each dimension and 
the full scale reached satisfactory levels of reliability. The confir-
matory factor analysis demonstrated a six-factor model con-
sisting of negative thinking about the future, negative thinking 
about the self, worry and agitation, depressed mood, somatiza-
tion, and loss of volition. We used the following overall measures 
of fit: 1) The χ
2, which tests the degree of agreement between a 
theoretical model and observed data but is sensitive to sample 
size.
29-30 Thus, some researchers suggest that the χ
2 may be re-
ported but should not be used as a main index.
31 2) The root mean 
square error of approximation (RMSEA), an index for estimat-
ing the whole population using sampled data. A RMSEA value 
of 0.05 or less indicates good fit or high agreement between the 
whole population and the sample, 0.05-0.08 indicates moderate 
agreement, and 0.10 or higher indicates low agreement.
32,33 3) 
The comparative fit index (CFI), which ranges between 0 and 1. 
A value of 0.90 or higher indicates high agreement between data 
and hypothesis.
30,31,34 4) The root mean square residual (RMR) is 
the square root of the average squared amount by which the sam-
ple variances and covariances differ from their estimates. It indi-
cates the mean correlation between the observed and hypothe-
sized data that are not explained by the model. A low RMR indi-
cates a high level of agreement between the hypothesis and the 
observed data. The measures of overall fit calculated in this study 
were all adequate (χ
2=3381.59, RMSEA=0.06, RMR=0.04, stan-
dardized RMR=0.05, NFI=0.92, NNFI=0.91, CFI=0.92, and 
GFI=0.92). Thus, the RMSEA was less than 0.10, the standard-
Table 4. Correlation analysis for LRDS, BDI, HAM-D and MMPI-D 
scale
LRDS BDI HAM-D MMPI-D scale
LRDS 0.778* 0.587* 0.502*
BDI 0.588* 0.453*
HAM-D 0.394*
*p<0.001. LRDS: Lee and Rhee Depression Scale, BDI: Beck Depres-
sion Inventory, HAM-D: Hamilton Depression Rating Scale, MMPI-
D scale: D scale on Minnesota Multiphasic Personality Inventory-2
Table 5. Area under ROC curve for each dimension
Dimension Area SE
Negative thinking about the future 0.724* 0.014
Negative thinking about the self 0.703* 0.015
Worry and agitation 0.780* 0.013
Depressed mood 0.739* 0.014
Somatization 0.722* 0.014
Loss of volition 0.744* 0.015
Full scale 0.777* 0.013
*p<0.001. ROC: receiver operating characteristic, SE: standard error
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ized RMR was close to 0.05, and the CFI and GFI were over 0.90. 
These results suggest that the data reflected the six-factor mod-
el of the LRDS. 
These data also indicated good concurrent validity in that 
they revealed significant and strong correlations with previous-
ly validated scales such as the BDI, HAM-D, and MMPI-D. Ac-
cording to a survey of mental health professionals about the cur-
rent use of depression rating scales in Korean mental health 
settings, psychiatrists usually prefer the BDI and HAM-D, in 
that order, and clinical psychologists usually prefer the BDI 
and MMPI. This survey suggests that currently used depression 
rating scales are not various at clinical practice. Reasons for not 
using particular scales included doubts about reliability and va-
lidity, lack of familiarity with the scale, and ability to diagnose 
and assess via psychiatric interviews without the assistance of 
scales.
12 Given the current state of clinical practice in Korea, the 
development of a valid and reliable standardized depression 
rating scale for the Korean population should not be postponed. 
In this context, the LRDS, which is correlated with depression 
scales that have been validated on an international level, can be 
a helpful in screening for depression.  
The LRDS is distinguished from existing scales such as the 
BDI with respect to items addressing somatic issues. Whereas 
the BDI contains items on sexual activity, work, fatigue, and heal-
th concerns, the LRDS contains the following items regarding 
somatic symptoms: 5) “My head aches and is heavy;” 11) “I feel 
pressure in my chest;” 17) “I have cold sweats and chills;” 23) “I 
have a fever in my whole body;” and 29) “My mouth is dry, and 
I have a bitter taste.” These somatic symptoms are observed fre-
quently among depressed people in Korea. Social stigma, such 
as the belief that “depression is a sign of a weak mind,” leads in-
dividuals to express distress in somatic rather than emotional 
terms. Thus, many patients with depression are referred to psy-
chiatry departments via departments of neurology and internal 
medicine. Therefore, the use of the LRDS to screen for depres-
sion will be useful not only in psychiatric but also in other de-
partments of hospitals. Compared with the BDI, the LRDS can 
avoid response bias through positively worded items such as “My 
future will be happier than my life is now” and “I still feel that 
life is worth living.” However, given that the LRDS contains no 
items pertaining to changes in appetite or sleep disturbances, 
which constitute common symptoms of depression, the use of 
both the BDI and the LRDS will increase true positives for de-
pression. 
In actual clinical practice, the accuracy with which depression 
is detected can be enhanced by using this scale with other de-
pression scales. Lewinsohn and Teri
35 reported that the hit rate 
was higher when BDI was used with their depression scale. Lee 
and Song
36 also reported that the simultaneous use of both BDI 
and another depression scale decreased false positives compared 
with the use of BDI alone. Completing the 30 items of the LRDS 
in addition to the BDI-21 may be burdensome for patients in 
clinical settings, suggesting that future studies should attempt to 
decrease the number of items and assess the validity and reli-
ability of the abbreviated instrument. 
According to the ROC analysis, the diagnostic utility of this 
scale was 77.7%, indicating that it can be used to diagnose de-
pression and to identify subjects experiencing depression for 
purposes of research. Use of this scale for research purposes will 
require specification of an objective cut-off score for classifying 
individuals into the depression group. It would be possible to 
find the relative position of each individual’s depression score 
in a norm table prepared by calculating standard scores based 
on the means and standard deviations of groups by condition 
and then converting the scores into T-scores in which the mean 
is 50 and the standard deviation is 10.
In general, a T-score of 70 or higher is suggested as the thresh-
old for depression, but we propose that scores +1.5 SD higher 
than the average T-scores be considered as indicative of depres-
sion. Indeed, use of this cut-off point in the present study would 
have placed 6.7% of the subjects into the depressed group. That 
is, if an individual’s score was 65 or higher, he or she would be 
placed in the depression group; lower scores would place the 
individual in the non-depressed group. However, the cut-off 
score is not an absolute standard. The tester can use the norm 
table to choose an appropriate standard according to the pur-
pose of the test. Indeed, the cut-off score can be set depending 
on the relative importance of false positives and false negatives. 
For example, if misclassifying non-depressed people as depressed 
(false positive) resulted in a serious situation, the possibility of 
false positives can be minimized by setting the cut-off score 
higher, and vice versa. 
Individuals are classified on the LRDS based on the T-score 
table according to sex and age. According to the table presented 
in the Appendix, the cut-off score is 65 for males and 70 for fe-
males. It should be remembered that an individual with a high 
score should not necessarily be diagnosed with depression. 
This study has the following limitations. First, this study at-
tempted discriminant validation of the scale by comparing the 
total scores of a group of patients with depression with those of 
a control group. However, comparisons with other psychiatric 
disorders, such as an anxiety disorder, are needed to strength-
en the discriminant validity. Second, we tested only the six-di-
mension model that we assumed would represent a good fit for 
the scale. Despite these limitations, the current study has im-
portant implications for future research. Although the internal 
consistency of this scale was satisfactory, its test-retest reliabili-
ty should be studied to enhance its reliability. Furthermore, fu-
ture investigations should examine other possible models includ-
ing three-, four-, and five-factor models.44  Psychiatry Investig 2012;9:36-44
Development of the LRDS
The current study is significant in that it is the first to devel-
op a culturally sensitive scale for screening depression in Ko-
rea. The LRDS is not only valid and reliable, it also offers cut-off 
scores on the basis of age and sex; it is a useful and easy tool to 
administer in clinical and research settings. 
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